{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:16Z","timestamp":1793675116907,"version":"4.5.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    This study evaluates the efficacy and safety of autologous serum eye drops (ASEDs) combined with sodium hyaluronate in treating dry eye disease (DED) after phacoemulsification cataract surgery. This retrospective cohort study included patients diagnosed with DED within 1 week to 1 month after cataract surgery at our hospital (August 2022\u2013July 2023). Patients were divided into a combined group (ASEDs\u2005+\u2005sodium hyaluronate, n\u2005=\u200548) and a monotherapy group (sodium hyaluronate only, n\u2005=\u200563). Propensity score matching was used to balance baseline characteristics, resulting in 48 patients in each group. Both groups were treated for at least 4 weeks. Clinical indicators, including Ocular Surface Disease Index (OSDI), Schirmer I test (SIT), tear breakup time (BUT), fluorescein staining, conjunctival hyperemia, and conjunctival impression cytology, were assessed before and after treatment. After propensity score matching, baseline characteristics were comparable (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). The mean age was 43.83\u2005\u00b1\u20058.84 years in the combined group and 43.93\u2005\u00b1\u20058.84 years in the monotherapy group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.865), with male proportions of 47.9% and 45.8%, respectively (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.779). Other variables, including body mass index, disease duration, OSDI, SIT, and BUT, also showed no significant differences. After 4 weeks, the combined group showed significantly greater improvements. OSDI scores decreased to 14.09\u2005\u00b1\u20054.22 versus 21.50\u2005\u00b1\u20054.82 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001); SIT increased to 10.23\u2005\u00b1\u20052.00\u2009mm versus 8.50\u2005\u00b1\u20051.50\u2009mm (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001); BUT extended to 8.18\u2005\u00b1\u20050.96 seconds versus 6.00\u2005\u00b1\u20051.00 seconds (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Fluorescein staining scores reduced to 0.56\u2005\u00b1\u20050.22 versus 1.86\u2005\u00b1\u20050.76 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), with conjunctival hyperemia and conjunctival impression cytology scores also significantly improved in the combined group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). ASEDs combined with sodium hyaluronate significantly improve both symptoms and ocular surface parameters in post-cataract DED patients, showing superior efficacy over monotherapy and promising clinical value.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043833","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:02:03Z","timestamp":1755543723000},"page":"e43833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The effect of autologous serum eye drops combined with sodium hyaluronate eye drops in the treatment of dry eye syndrome after cataract surgery"],"prefix":"10.1097","volume":"104","author":[{"given":"Lei","family":"Jiang","sequence":"first","affiliation":[{"name":"Ophthalmology Department, The First People\u2019s Hospital of Linping District, Hangzhou City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The First People\u2019s Hospital of Linping District, Hangzhou City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Shu","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The First People\u2019s Hospital of Linping District, Hangzhou City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangli","family":"Fan","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The First People\u2019s Hospital of Linping District, Hangzhou City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8869-7748","authenticated-orcid":false,"given":"Zhen","family":"Deng","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The First People\u2019s Hospital of Linping District, Hangzhou City, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(05)70803-5","article-title":"Age-related cataract.","volume":"365","author":"Asbell","year":"2005","journal-title":"Lancet"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1753-4887.1989.tb02848.x","article-title":"Associations between nutrition and cataract.","volume":"47","author":"Taylor","year":"1989","journal-title":"Nutr Rev"},{"key":"R3-20260911","first-page":"CD006366","article-title":"Surgery for postvitrectomy cataract.","volume":"1","author":"Do","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/ciia.2007.2.1.105","article-title":"Cataract surgery and quality of life implications.","volume":"2","author":"Morris","year":"2007","journal-title":"Clin Interv Aging"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ICU.0b013e328333ea2f","article-title":"Cataract surgery following phakic intraocular lens implantation.","volume":"21","author":"Moshirfar","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11892-021-01418-z","article-title":"Cataract surgery considerations for diabetic patients.","volume":"21","author":"Go","year":"2021","journal-title":"Curr Diab Rep"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/ICU.0000000000000909","article-title":"Cataract surgery and the risk of progression of macular degeneration.","volume":"34","author":"Bhandari","year":"2023","journal-title":"Curr Opin Ophthalmol"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.70.6.418","article-title":"Hyaluronidase and sodium hyaluronate in cataract surgery.","volume":"70","author":"Calder","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/j.jcjo.2018.11.012","article-title":"Cataract surgery in a patient with apparent sodium hyaluronate allergy.","volume":"54","author":"Purgert","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2006.04.017","article-title":"Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy.","volume":"142","author":"Schulze","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4103\/IJO.IJO_2756_22","article-title":"Autologous serum eye drops in dry eye disease: preferred practice pattern guidelines.","volume":"71","author":"Vazirani","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10792-024-03402-4","article-title":"Effects of autologous serum and artificial tears on corneal sensation and tear film stability in patients with mild to moderate xerophthalmia after cataract surgery.","volume":"45","author":"Wang","year":"2025","journal-title":"Int Ophthalmol"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jcrs.2005.01.014","article-title":"Combination of transepithelial phototherapeutic keratectomy and autologous serum eyedrops for treatment of recurrent corneal erosions.","volume":"31","author":"Holzer","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"e026770","DOI":"10.1136\/bmjopen-2018-026770","article-title":"The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial.","volume":"8","author":"Balal","year":"2018","journal-title":"BMJ Open"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"e080474","DOI":"10.1136\/bmj-2024-080474","article-title":"Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: non-inferiority randomised controlled trial.","volume":"386","author":"Li","year":"2024","journal-title":"BMJ"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jfo.2020.06.045","article-title":"Place du NIBUT automatis\u00e9 dans l\u2019\u00e9valuation multimodale de la surface oculaire dans le syndrome sec avec le Lacrydiag [Multimodal evaluation of the ocular surface using a the new Lacrydiag device].","volume":"44","author":"Remongin","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/1744666X.2024.2358157","article-title":"The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sj\u00f6gren\u2019s syndrome related dry eye.","volume":"20","author":"Huo","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study.","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clae.2016.12.008","article-title":"Conjunctival impression cytology evaluation of patients with dry eye disease using scleral contact lenses.","volume":"40","author":"Weber","year":"2017","journal-title":"Cont Lens Anterior Eye"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pop.2015.05.012","article-title":"Cataracts.","volume":"42","author":"Thompson","year":"2015","journal-title":"Prim Care"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jtos.2020.09.006","article-title":"Ocular surface diabetic disease: a neurogenic condition?","volume":"19","author":"Di Zazzo","year":"2021","journal-title":"Ocul Surf"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.eye.6700721","article-title":"The use of autologous serum tears in persistent corneal epithelial defects.","volume":"18","author":"Young","year":"2004","journal-title":"Eye (Lond)"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2019.08.018","article-title":"Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology.","volume":"127","author":"Shtein","year":"2020","journal-title":"Ophthalmology"},{"key":"R24-20260911","first-page":"CD009327","article-title":"Autologous serum eye drops for dry eye.","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ACI.0000000000000770","article-title":"Autologous serum eye drops for ocular surface disorders.","volume":"21","author":"Cui","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:02:49Z","timestamp":1789153369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":25,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043833","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"2025-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}